HIV impacts heavily on the operating costs of companies in sub-Saharan Africa. with many companies now providing antiretroviral therapy (ART) programmes in the workplace. A full cost-benefit analysis of workplace ART provision has not been conducted using primary data. We developed a dynamic health-state transition model to estimate the economic impact of HIV and the cost-benefit of A... https://www.socialstudiesscholar.com/